All SightGlass Vision Articles
-
676Latest Myopia NewsSightGlass Shares Positive Results at American Academy of Optometry 2023
October 16,2023 NEW ORLEANS, La. — At the American Academy of Optometry’s 2023 Annual Meeting, SightGlass Vision shared three studies that further...
-
814ClinicalNext-Gen Spectacle Designs for Myopia Management: What We Know Now
October 2, 2023 By Nabin Paudel, BOptom, PhD Myopia management using optical interventions, particularly spectacle lenses, has evolved over the past few...
-
444Latest Myopia NewsSightGlass Vision Releases First White Paper on DOT Lenses
September 20, 2023 LOS ALTOS, Calif. — SightGlass Vision’s Diffusion Optics Technology (DOT) spectacle lenses are the subject of a recently released...
-
450Latest Myopia NewsSightGlass Presents Four-Year Results of CYPRESS Trial at CCOS
September 5, 2023 CHANGSHA, China — At the Congress of the Chinese Ophthalmological Society (CCOS) in Changsha, SightGlass Vision shared the four-year results...
-
935Latest Myopia NewsVTI Appoints Dr. Juan Carlos Aragón as CEO and Executive Director
ATLANTA — Visioneering Technologies, Inc. (ASX: VTI), a medical device company and producer of the NaturalVue Multifocal 1 Day Contact Lenses, announced...
-
759Latest Myopia NewsTHE Myopia Meeting Brings Live Myopia Management Education to Canada
November 9, 2022 TORONTO – With Canada the first country to establish myopia management as the standard of care and offering more...
-
781Latest Myopia NewsSightGlass Vision’s DOT Spectacles Found to be Effective for Reducing Myopia Progression
October 25, 2022 LOS ALTOS, Calif. — New findings from SightGlass Vision’s three-year CYPRESS clinical trial have highlighted the efficacy of the...
-
1.4KLatest Myopia NewsThe International Myopia Conference Breaks All Records
September 12, 2022 ROTTERDAM, The Netherlands — After a three-year hiatus, the International Myopia Conference returned with its best attended event since...
-
1.3KLatest Myopia NewsSightGlass Vision Spectacles Slow Myopia Progression for 6- and 7-Year-Olds
June 23, 2022 PALO ALTO, Calif. — In analyzing two-year data from SightGlass Vision’s CYPRESS clinical trial, experts have learned that the...
-
2.4KEditor’s PerspectiveInnovative Myopia Control Spectacle Lenses on the Horizon
June 1, 2022 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE There is good reason to slow the progression of juvenile-onset myopia....
-
1.5KClinicalReview of Myopia Management Spectacles: MiYOSMART, Stellest, and SightGlass
June 1, 2022 By Dean Psarakis, B.Optom, Senior Research Optometrist, Brien Holden Vision Institute Novel spectacle designs comprising D.I.M.S., H.A.L.T., and D.O.T....
-
6.5KClinicalECPs Share Real-World Experience with DOT Spectacle Lenses
sponsored content June 1, 2022 One of few spectacle lenses available to slow the progression of myopia, SightGlass Vision’s novel Diffusion Optics...
-
1.2KResources & Multimedia‘Up Close With’ Juan Carlos Aragón of CooperVision Specialty EyeCare
April 4, 2022 To find out what’s new with CooperVision Specialty EyeCare, particularly its growing list of orthokeratology materials and designs, Review...
-
1.3KLatest Myopia NewsSightGlass Vision Announces New Executive Team
March 24, 2022 PALO ALTO, Calif. — SightGlass Vision announced the appointment of three new leadership positions to its executive team. Andrew...
-
3.1KClinicalExperiencing SightGlass Vision’s Spectacle Lenses
December 15, 2021 By Joe Rappon, OD, MS, FAAO, and Kylvin Ho, OD, FIAOMC As children continue to develop myopia at earlier...
-
2.9KClinicalThe Latest Science on Myopia Control Spectacles
sponsored content November 1, 2021 By Mark Bullimore, MCOptom, PhD, FAAO Effective spectacle options for myopia control have finally arrived. They are...
-
1.7KLatest Myopia NewsCooperVision to Present Myopia Management Research at BCLA Conference
June 8, 2021 SAN RAMON, Calif. — CooperVision is slated to present research findings from more than 20 investigations at the upcoming...
-
3.7KLatest Myopia NewsOIS to Hold Virtual Myopia Innovation Showcase April 29
April 12, 2021 CLICK HERE to view the presentation after April 29, 2021. The Ophthalmology Innovation Summit (OIS) will host a virtual...
-
6.7KIn The PipelineEssilor’s Rick Gadd Discusses Acquisition of SightGlass
March 3, 2021 Rick Gadd, President, Essilor North America, recently met with Review of Myopia Management’s Editor-in-Chief John Sailer to discuss the company’s...
-
4.3KIn The PipelineCooperVision President Daniel McBride Discusses Acquisition of SightGlass
March 3, 2021 Last month, CooperCompanies and EssilorLuxottica announced that they were teaming up to acquire SightGlass Vision. The goal of the joint...
-
4.3KIn The PipelineCooperVision and EssilorLuxottica Partner to Commercialize SightGlass Myopia Management Lens
February 3, 2021 SAN RAMON, Calif. and CHARENTON-LE-PONT, France – CooperCompanies and EssilorLuxottica entered a joint venture agreement to accelerate commercialization of...
-
3.8KIn The PipelineSightGlass Vision Achieves CE Mark Allowing European Marketing for Novel Eyeglasses
June 3, 2020 PALO ALTO, California – SightGlass Vision, Inc. today announced it has achieved Conformité Européene (CE) Mark declaration on its first product...
-
2.4KIn The PipelineSightGlass Vision Reports Positive Interim Data From Pivotal Clinical Trial of Novel Eyeglasses for Myopia Management in Children
April 2, 2020 Palo Alto, California – SightGlass Vision, Inc., a clinical-stage life sciences company focused on ending myopia, announced topline results from a...
-
7.9KKey IssuesThe Global Myopia Awareness Coalition: What It Is and Why It Matters
Tens of millions of myopic children around the world need our help.
-
3.3KIn The PipelineSightGlass Presents CYPRESS Study Baseline Data at International Myopia Conference
CYPRESS is a multi-center, double-masked, randomized controlled pivotal clinical study.
-
2.9KLatest Myopia NewsJobson Joins Global Myopia Awareness Coalition (GMAC)
Jobson Medical Information will be the official North American media sponsor.
-
5.1KEditor’s PerspectiveThank You, Global Myopia Awareness Coalition
Jobson Optical Research, sponsored by Essilor, polled more than 300 optometrists in the U.S.